TrialClinical and translational science2024

Safety, pharmacokinetics, and pharmacodynamics of anti-IL-4Rα antibody SHR-1819 in healthy subjects: A randomized, controlled phase I study.

Na Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.